Business Description
Healthlead PCL
ISIN : THA598010009
Compare
Compare
Traded in other countries / regions
HL.Thailand IPO Date
2021-12-03Description
Healthlead PCL is engaged in the business of healthcare-related and medical products. It operates in the pharmacy business, distribution of medical supplies, cosmeceuticals, and dietary supplements. medical equipment and various health products. as well as in business regarding invention business, developing, importing, and distributing healthcare products. The Group operates in a single line of business which is the pharmacy business. The Group operates in a single geographic area in Thailand.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.96 | |||||
| Equity-to-Asset | 0.67 | |||||
| Debt-to-Equity | 0.27 | |||||
| Debt-to-EBITDA | 1.51 | |||||
| Interest Coverage | 8.65 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 4.97 | |||||
| Beneish M-Score | -2.5 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 15.4 | |||||
| 3-Year EBITDA Growth Rate | 17.3 | |||||
| 3-Year EPS without NRI Growth Rate | 12.5 | |||||
| 3-Year FCF Growth Rate | -53.2 | |||||
| 3-Year Book Growth Rate | 90.2 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 15.12 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 13.8 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 62.46 | |||||
| 9-Day RSI | 57.05 | |||||
| 14-Day RSI | 50.58 | |||||
| 6-1 Month Momentum % | -27.03 | |||||
| 12-1 Month Momentum % | -34.68 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.74 | |||||
| Quick Ratio | 2.45 | |||||
| Cash Ratio | 2.31 | |||||
| Days Inventory | 65.43 | |||||
| Days Sales Outstanding | 0.71 | |||||
| Days Payable | 36.87 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.88 | |||||
| Dividend Payout Ratio | 0.6 | |||||
| Forward Dividend Yield % | 1.88 | |||||
| 5-Year Yield-on-Cost % | 1.88 | |||||
| Shareholder Yield % | -1.13 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 23.13 | |||||
| Operating Margin % | 5.24 | |||||
| Net Margin % | 4.23 | |||||
| FCF Margin % | 1.54 | |||||
| ROE % | 7.99 | |||||
| ROA % | 5.59 | |||||
| ROIC % | 11.65 | |||||
| 3-Year ROIIC % | 5.9 | |||||
| ROC (Joel Greenblatt) % | 19.95 | |||||
| ROCE % | 9.15 | |||||
| Years of Profitability over Past 10-Year | 5 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 30.61 | |||||
| Forward PE Ratio | 22.16 | |||||
| PE Ratio without NRI | 32.8 | |||||
| PS Ratio | 1.23 | |||||
| PB Ratio | 2.33 | |||||
| Price-to-Tangible-Book | 2.39 | |||||
| Price-to-Free-Cash-Flow | 80.39 | |||||
| Price-to-Operating-Cash-Flow | 18.58 | |||||
| EV-to-EBIT | 18.49 | |||||
| EV-to-EBITDA | 11.46 | |||||
| EV-to-Revenue | 1.09 | |||||
| EV-to-FCF | 70.77 | |||||
| Price-to-Graham-Number | 1.87 | |||||
| Price-to-Net-Current-Asset-Value | 6.21 | |||||
| Price-to-Net-Cash | 54.67 | |||||
| Earnings Yield (Greenblatt) % | 5.42 | |||||
| FCF Yield % | 1.25 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return %
Total Annual Return %
Healthlead PCL Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ฿) | 1,800.444 | ||
| EPS (TTM) (฿) | 0.268 | ||
| Beta | 0 | ||
| Volatility % | 31.7 | ||
| 14-Day RSI | 50.58 | ||
| 14-Day ATR (฿) | 0.271685 | ||
| 20-Day SMA (฿) | 7.9175 | ||
| 12-1 Month Momentum % | -34.68 | ||
| 52-Week Range (฿) | 7.1 - 12.7 | ||
| Shares Outstanding (Mil) | 272 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Healthlead PCL Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Healthlead PCL Stock Events
| Event | Date | Price(฿) | ||
|---|---|---|---|---|
| No Event Data | ||||
Healthlead PCL Frequently Asked Questions
What is Healthlead PCL(BKK:HL)'s stock price today?
The current price of BKK:HL is ฿8.20. The 52 week high of BKK:HL is ฿12.70 and 52 week low is ฿7.10.
When is next earnings date of Healthlead PCL(BKK:HL)?
The next earnings date of Healthlead PCL(BKK:HL) is .
Does Healthlead PCL(BKK:HL) pay dividends? If so, how much?
The Dividend Yield % of Healthlead PCL(BKK:HL) is 1.88% (As of Today), Highest Dividend Payout Ratio of Healthlead PCL(BKK:HL) was 0.66. The lowest was 0.37. And the median was 0.52. The Forward Dividend Yield % of Healthlead PCL(BKK:HL) is 1.88%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers